![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_8159b09a6bebd9e5751360e57f770ab8.svg) | Clozapine | Ki | 3.7 [1], 11.0 [2], 23.0 [3], 47.86 [4] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_8b78ef0953132cb6729f40caa0d6bbea.svg) | Olanzapine | Ki | 7.3 [1], 14.0 [2], 15.0 [3], 60.0 [4] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_1702ec4e91a6e6ac7ec0735114adb8a6.svg) | Ziprasidone | IC50 | 11.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_1702ec4e91a6e6ac7ec0735114adb8a6.svg) | Ziprasidone | Ki | 1.9 [1], 11.0 [2], 12.0 [3] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_712d7bf3cb291229e4b03575585bc48f.svg) | N-(4,5-Dihydro-1H-imidazol-2-yl)-5-methylquinoxalin-6-amine | Ki | 1400.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_be4565ca8c20c1d9804fa640fd1584d5.svg) | Risperidone | Ki | 0.69 [1], 1.0 [2], 2.3 [3] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_ebac36f7213da3162d29205ab4152aca.svg) | Prazosin | IC50 | 0.17 [1], 0.2 [2], 0.86 [3] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_6bd8428f24df55bebd5446ef40e0614c.svg) | Brimonidine | Ki | 1800.0 [1], 1900.0 [2] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_6cf5ecbb9a1c42bdc42ce186d840229c.svg) | 2-Naphthalenecarboxamide, N-(4-(4-(2-methoxyphenyl)-1-piperazinyl)butyl)- | Ki | 5.0 [1], 25.0 [2] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_135e1b51c4285a8ab5ce02f8e0f91fbe.svg) | N-[4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butyl]-1-benzothiophene-2-carboxamide | Ki | 370.0 [1], 2000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_fca61421b152236f16e5a0ef02891e33.svg) | N-(4,5-Dihydro-1H-imidazol-2-yl)-5-methyl-1,2,3,4-tetrahydroquinoxalin-6-amine | Ki | 8700.0 [1], 8900.0 [2] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_1a2ef0969fddb77e7c383253c8b871b7.svg) | Clonidine | Ki | 510.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_7ce5c90b273b41810bee3170ac9401d3.svg) | Haloperidol | Ki | 5.7 [1], 19.0 [2] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_c871e436119b1d6f92ea7571ed4647e5.svg) | Quetiapine | Ki | 4.5 [1], 58.0 [2] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_01a74ff12e6bf089ced324ef974b490e.svg) | Cisapride | IC50 | 30.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_df20649e63f6814da658fbc9fd2ea41a.svg) | 4-Amino-5-chloro-N-((hexahydro-1H-pyrrolizin-1-yl)methyl)-2-methoxybenzamide hydrochloride | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_df20649e63f6814da658fbc9fd2ea41a.svg) | 4-Amino-5-chloro-N-((hexahydro-1H-pyrrolizin-1-yl)methyl)-2-methoxybenzamide hydrochloride | Ki | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_bbe06f8fbcdad7156addc46c54182570.svg) | (2R)-1-[4-(4-Methylbenzyl)piperazinoacetyl]-2-methylindoline | IC50 | 1118.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_bbe06f8fbcdad7156addc46c54182570.svg) | (2R)-1-[4-(4-Methylbenzyl)piperazinoacetyl]-2-methylindoline | Ki | 1118.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_760c3502a4edf61c27018ca53a36c234.svg) | 4-Amino-N-[(4R)-1-azatricyclo[3.3.1.03,7]nonan-4-yl]-5-chloro-2-methoxybenzamide | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_aead188f3b3f54c8556c8e4fc38b8619.svg) | 7-Nitro-3-{[2-(phenyloxy)phenyl]amino}-4H-1,2,4-benzothiadiazin-5-ol 1,1-dioxide | IC50 | 1000.0 [1], 25000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_e37299680aaf3f246a8f09a8f121c75a.svg) | N-(4,5-Dihydro-1H-imidazol-2-yl)-5-methyl-3,4-dihydro-2H-1,4-benzoxazin-6-amine | Ki | 470.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_581904209426a60e1517daf741e803ea.svg) | (7-Chloro-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-[1-(2-methoxy-phenyl)-piperidin-4-ylmethyl]-amine | Ki | 53.0 [1], 181.0 [2] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_df20108b51b3e9526d663e98292b0c90.svg) | N-(4,5-Dihydro-1H-imidazol-2-yl)quinoxalin-6-amine | Ki | 11000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_822b68838fffd6964517f5b8f84eafba.svg) | Dopamine | Ki | 2511.89 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_13ca8a7707d990fde72fc2db625d91c5.svg) | Norepinephrine | Ki | 2600.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_faac9f61879fd14d1ee20cc8818ffd60.svg) | Atenolol | IC50 | 230.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_79b99809a4327da541aa2304e553f873.svg) | Terfenadine | IC50 | 2340.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_fdb97b472d1c5c6008e15a1463e41228.svg) | Fenoldopam | Ki | 151.36 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_10e671aa0c2e8af205d779ba113db7f0.svg) | Zafirlukast | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_0670ec52c0fe87acac95c68ab7833293.svg) | Moxonidine | Ki | 30000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_b3480c65a1186fd9366ffe990bf8519c.svg) | Apraclonidine | Ki | 180.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_112cb7603ef103663fb2d68ed01dbedd.svg) | Sertindole | Ki | 1.8 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_b1ddc5a5237d227b689739fcd0fddf19.svg) | Ipsapirone | IC50 | 500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_ddea5339ebd2113aa6ec148dcd1aad53.svg) | Ebastine | IC50 | 183.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_379b6c972d2dc49bd0d5d6604783ef3a.svg) | Pizotifen | Ki | 75.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_6cb3ea27fe013e7dda2c01a588aff4ff.svg) | Zotepine | Ki | 3.4 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_ff8d4194409d8fceaa071169fcd4b4d4.svg) | GR-127935 | Ki | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_7bee8962f9fb089ffc0ed5d64bc0139f.svg) | Sarpogrelate hydrochloride | IC50 | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_4d48b9507ee0a33cdb2b11006366144b.svg) | 4-[(1R,2S)-3-(4-Benzylpiperidin-1-yl)-1-hydroxy-2-methylpropyl]phenol | Ki | 180.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_d2bd8032afa36c172d5f1610288b68e2.svg) | Vilazodone | IC50 | 1980.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_4d4c684eaa25cf49f51d35a47e1b75dd.svg) | 4-[2-(Dipropylamino)ethyl]benzene-1,2-diol | Ki | 1995.26 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_0ef8e49ad0f17d5eb8cd799eb0c079f1.svg) | 7-Methyl-6,7,8,9,14,15-hexahydro-5H-benz[d]indolo[2,3-g]azecine | Ki | 11.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_7e3c87574db588f1ff3e2334e06ef74b.svg) | 3-[[4-(4-Chlorophenyl)piperazin-1-yl]methyl]pyrazolo[1,5-a]pyridine | Ki | 240.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_404ee23e4ae97a72a8990c4ff78f508e.svg) | N-Desmethylolanzapine | Ki | 80.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_da9a9cc8e5c7237e38b5596d82a38c22.svg) | N-[4-[4-(2-Methoxyphenyl)piperazin-1-yl]butyl]pyrazolo[1,5-a]pyridine-2-carboxamide | Ki | 26.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_3f46f6bc77a0c33c9a5797ca9fe81d84.svg) | 1-[4-(4-Chlorobenzyl)piperazinoacetyl]indoline | IC50 | 88.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_421b8d1934e3715ea1028700fe65fa1f.svg) | N-(4-(4-(2-Methoxyphenyl)piperazin-1-yl)butyl)benzo[b]thiophene-2-carboxamide | Ki | 15.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_760c170bad01a1c163e866a9dbce9f05.svg) | N-(4-(4-(2-Methoxyphenyl)piperazin-1-yl)butyl)benzofuran-2-carboxamide | Ki | 8.6 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_6b9242dd60975380ab191989a8f31ee7.svg) | Unii-N4Y2V13I7F | Ki | 6.75 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_92d614d5709d3419bee51012767bc3dd.svg) | 1-[2-(3,4-Dihydro-1H-2-benzopyran-1-yl)ethyl]-4-(4-fluorophenyl)piperazine | Ki | 38.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_bcbb36a6cad84298c3dc74af8f90788c.svg) | N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butyl)benzofuran-2-carboxamide | Ki | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_5f77492003e9538e3eeea4c0f250874e.svg) | Eptapirone | Ki | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_67a79681ecc55144999fb6494a50c7c5.svg) | Mazapertine | Ki | 1.3 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_ed0696f4063527c90599e250ac09b094.svg) | 2-(1-Benzofuran-6-yl)-N-[[(1R)-5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl]methyl]-N-methylethanamine | Ki | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_e96e010d8c086ecdf1369fcf207bded2.svg) | 3-Isopropyl-bicyclo[2.2.1]hept-2-ylamine | Ki | 100000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_54c251e435d71fda297bb5e61ab01aa9.svg) | 3-[2-(Benzylamino)ethoxy]phenol | Ki | 5291.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_97661845ae31eac8f066cbf961094f30.svg) | N-((Hexahydro-1H-pyrrolizin-1-yl)methyl)-6-chloroimidazo(1,2-a)pyridine-8-carboxamide hydrochloride | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_af27d7583af96b28cfd3eb5fd665467b.svg) | 2-(1,4-Benzodioxan-6-ylamino)-2-imidazoline | Ki | 2400.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_629f7f5cb474eeee7d355a412eb99a09.svg) | 1-(2,3-Dihydro-1,4-benzodioxin-6-yl)-4-(2,3-dihydro-1H-inden-2-ylmethyl)piperazine | Ki | 967.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_3a810018733eff075ae6c928a1984e94.svg) | 3-(4-Benzyl-piperazin-1-yl)-phenol | Ki | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_9bc49b50df2b2aec932f139a88a8441a.svg) | 4-(5-Fluoro-2-indanylmethyl)-2-imidazoline | Ki | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_1a25fd3b14cdd6366b9860277ee1d8db.svg) | 2-Hydroxymethyl Olanzapine | Ki | 12.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_a54295420de0c74beb2bfea6b88a2fd2.svg) | Imidazolidine, 2-(2-methylphenylimino)- | Ki | 2500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_19486e79148b6b1ab710f15154d58c1f.svg) | (3R,3As)-7,8-dimethoxy-3-[[4-[(E)-3-phenylprop-2-enyl]piperazin-1-yl]methyl]-3a,4-dihydro-3H-chromeno[4,3-c][1,2]oxazole | Ki | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_8b7abc48edf30a2538d03e3d1bf746fe.svg) | (3R,3As)-7,8-dimethoxy-3-[[4-[(E)-2-methyl-3-phenylprop-2-enyl]piperazin-1-yl]methyl]-3a,4-dihydro-3H-chromeno[4,3-c][1,2]oxazole | Ki | 380.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_79bd9e6d4ab943f8b2cd1d58bcadd7d7.svg) | (3R,3As)-7,8-dimethoxy-3-[[4-[(E)-3-phenylbut-2-enyl]piperazin-1-yl]methyl]-3a,4-dihydro-3H-chromeno[4,3-c][1,2]oxazole | Ki | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_94ad66984b1c22a17dc1120f4d64098c.svg) | N-[4-[4-(2-Methoxyphenyl)piperazin-1-yl]butyl]pyrazolo[1,5-a]pyridine-4-carboxamide | Ki | 28.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_a0f42519f9840e9004bac9cb0983e574.svg) | N-[4-[4-(2-Methoxyphenyl)piperazin-1-yl]butyl]pyrazolo[1,5-a]pyridine-7-carboxamide | Ki | 18.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_d379d5fb176c75ea632df5587a63b4b5.svg) | N-[4-[4-(2-Methoxyphenyl)piperazin-1-yl]butyl]pyrazolo[1,5-a]pyridine-5-carboxamide | Ki | 32.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_be3958895216acbfbdae75f591f08115.svg) | 2-{[4-(2-Methoxyphenyl)piperazino]methyl}imidazo[1,2-a]pyridine | Ki | 98.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_140b4bd9842346bf8bd8ab5915cca0d3.svg) | 1-[2-[4-(6-Fluoro-1H-indol-3-yl)-3,6-dihydro-2H-pyridin-1-yl]ethyl]-3,4-dihydro-1H-isochromene-6-carboxamide | Ki | 16.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_4f44aba651a0b3cb30f937f6b1ceb99c.svg) | 5-[2-[4-(2,3-Dimethylphenyl)piperazin-1-yl]ethyl]-2H-benzotriazole | Ki | 67.61 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_37ed7c25ce030596bd0a29c1048b13e4.svg) | N-[4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butyl]-5-iodo-1-benzofuran-2-carboxamide | Ki | 300.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_50d96cab7028da2083f25993fe30f872.svg) | 2-N-[2-(4-Fluorophenoxy)ethyl]-4-N-[(1S)-1-phenylethyl]pyridine-2,4-diamine | Ki | 8.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_39ca73c13f290e4bde104a81472b8013.svg) | N-[4-[4-(2-Methoxyphenyl)piperazin-1-yl]butyl]pyrazolo[1,5-a]pyridine-6-carboxamide | Ki | 19.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_4bb431c836e3181c5a20ef6987b0cdde.svg) | N-[4-[4-(2-Methoxyphenyl)piperazin-1-yl]butyl]pyrazolo[1,5-a]pyridine-3-carboxamide | Ki | 48.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_ae13027e000a497a0df355bcdb18b02f.svg) | 1-[1-(6-Chloro-1,3-benzodioxole-5-ylmethyl)-4-piperidinyl]-1H-benzimidazole-2(3H)-one | IC50 | 1330.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_701f91822abbb008948cc76c6ce601bd.svg) | 3-[1-[(6-Chloro-1,3-benzodioxol-5-yl)methyl]piperidin-4-yl]-5-methyl-1H-benzimidazol-2-one | IC50 | 4920.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_46e7f9afc5a9ce70b8ff40902cce1ada.svg) | 8-(2,1,3-Benzothiadiazol-5-ylmethyl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one | IC50 | 4250.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_7fb20d567ca2ccab784156a977776fe8.svg) | 1-[3-(6-Chloro-1,3-benzodioxole-5-ylmethylamino)propyl]-1H-benzimidazole-2(3H)-one | IC50 | 174.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_a7589375cd013885f6bf32c7329b1f6d.svg) | (6-Chloro-1,3-benzodioxol-5-yl)methyl 4-(2-oxo-3H-benzimidazol-1-yl)piperidine-1-carboxylate | IC50 | 1340.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_a6b75df648ae97ff00e6ac756c9fac99.svg) | 5-(2-(4-(1-Naphthyl)piperazinyl)ethyl)oxindole | IC50 | 45.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_e44b2f6a8aee4669e283d7790cff2c2a.svg) | N-[4-[4-(2-Methoxyphenyl)piperazin-1-yl]butyl]tricyclo[8.2.2.24,7]hexadeca-1(13),4,6,10(14),11,15-hexaene-5-carboxamide | Ki | 3.9 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_9d395b1d03e67058a70b67907bb03cea.svg) | 2-[4-[4-(7-Hydroxynaphthalen-1-yl)piperazin-1-yl]butyl]-4-methyl-1,2,4-triazine-3,5-dione | Ki | 24.5 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_ce5a4fa26572f2d0da25426b5abeee5c.svg) | 2-[4-[4-(7-(111C)Methoxynaphthalen-1-yl)piperazin-1-yl]butyl]-4-methyl-1,2,4-triazine-3,5-dione | Ki | 32.2 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_a32a724bd0b4f1e520690d6c5c589b49.svg) | 6-(4-Chlorophenyl)-3-[2-[4-(2-chlorophenyl)piperazin-1-yl]ethyl]-1,7-dihydropyrrolo[2,3-d]pyrimidine-2,4-dione | Ki | 2.64 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_8b2c58e403ca56ae2dacb89681a2938b.svg) | 3-[2-[4-(2-Chlorophenyl)piperazin-1-yl]ethyl]-6-(4-methylphenyl)-1,5-dihydropyrrolo[3,2-d]pyrimidine-2,4-dione | Ki | 17.26 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_86adfabb13db4e9d3d08d1dac26192c3.svg) | 8-(3-Phenoxybenzyl)-1-phenyl-1,3,8-triazaspiro[4.5]decane-4-one | IC50 | 2830.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_0681ff41984d7633d3d045cc9f51d1e2.svg) | N-(Diaminomethylidene)-9-hydroxy-9-methylfluorene-2-carboxamide;hydrochloride | Ki | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_5773aaf1e7c2c2043e0054bceaf4f918.svg) | 1-[(Dimethylamino)methyl]-2,3-dihydro-1H-indene-4,5-diol | Ki | 6900.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_34253f3c344806ff4700be3da7ae2e85.svg) | 1H-Indene-4,5-diol, 2,3-dihydro-1-[(methylamino)methyl]- | Ki | 2000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_b6850c360a7a0e43321c9631954803aa.svg) | 1H-Indene-4,5-diol, 1-(aminomethyl)-2,3-dihydro- | Ki | 2250.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_ce2a62073b41edec09fd585603d7781c.svg) | 1-[(Dipropylamino)methyl]-2,3-dihydro-1H-indene-4,5-diol | Ki | 7400.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_456a922f76bb78ee2004d33067425339.svg) | 1H-Indene-5,6-diol, 1-(aminomethyl)-2,3-dihydro- | Ki | 26000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_b62072c1591822d7c7c163995fc7df0c.svg) | 4-[2-Hydroxy-3-[4-hydroxy-4-(4-methylbenzyl)piperidino]propyl]phenol | Ki | 5915.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_35b8c15353c915b375a313c893cba9e8.svg) | 2-[10-[3-[4-(1,3-Dimethyl-2,6-dioxopyrimidin-4-yl)piperazin-1-yl]propyl]phenothiazin-2-yl]acetic acid | IC50 | 430.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_ba8429a50201da47244e3996b9619e80.svg) | 2-[4-(4-Chloro-benzyl)-piperazin-1-yl]-N-methyl-N-phenyl-acetamide | Ki | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_9f23f1177b91903791ed61e0631346ce.svg) | (3R,3As)-7,8-dimethoxy-3-[[4-(naphthalen-2-ylmethyl)piperazin-1-yl]methyl]-3a,4-dihydro-3H-chromeno[4,3-c][1,2]oxazole | Ki | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/adrenergic-receptor-alpha-1_41f307b20ff46950c25c77ef74178e5a.svg) | 5-Iodo-N-[4-[4-(2-methoxyphenyl)piperazin-1-yl]butyl]-1-benzofuran-2-carboxamide | Ki | 5.9 [1] |